Development of a ghrelin receptor inverse agonist for positron emission tomography.
cancer
copper-64
growth hormone secretagogue receptor (GHS-R)
prostate cancer
small animal imaging
Journal
Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965
Informations de publication
Date de publication:
02 Mar 2021
02 Mar 2021
Historique:
received:
05
11
2020
accepted:
01
02
2021
entrez:
22
3
2021
pubmed:
23
3
2021
medline:
23
3
2021
Statut:
epublish
Résumé
Imaging of Ghrelin receptors
Identifiants
pubmed: 33747360
doi: 10.18632/oncotarget.27895
pii: 27895
pmc: PMC7939532
doi:
Types de publication
Journal Article
Langues
eng
Pagination
450-474Informations de copyright
Copyright: © 2021 Bergmann et al.
Déclaration de conflit d'intérêts
CONFLICTS OF INTEREST Authors have no conflicts of interest to declare.
Références
Molecules. 2018 Dec 23;24(1):
pubmed: 30583594
Front Oncol. 2017 Jan 09;6:265
pubmed: 28119851
Horm Res. 2001;56 Suppl 1:93-7
pubmed: 11786694
Sci Rep. 2017 Jun 16;7(1):3756
pubmed: 28623364
Regul Pept. 2010 Aug 9;163(1-3):7-17
pubmed: 20382189
J Biol Chem. 2004 Dec 17;279(51):53806-17
pubmed: 15383539
Peptides. 2014 Apr;54:81-8
pubmed: 24468548
Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6320-5
pubmed: 18443287
J Med Chem. 2017 Sep 14;60(17):7256-7266
pubmed: 28719746
Cancer Lett. 2016 Dec 1;383(1):125-134
pubmed: 27693462
Prostate. 2012 Jun 1;72(8):825-33
pubmed: 21919027
Curr Pharm Des. 2020;26(14):1614-1621
pubmed: 31880242
J Nucl Med. 2014 Jul;55(7):1157-63
pubmed: 24790217
Structure. 2019 Mar 5;27(3):537-544.e4
pubmed: 30686667
Front Oncol. 2019 Oct 16;9:1014
pubmed: 31681567
J Med Chem. 2018 Feb 8;61(3):1261-1275
pubmed: 29327929
Eur J Med Chem. 2013;70:434-46
pubmed: 24184988
Pharmacol Rev. 2014 Oct;66(4):984-1001
pubmed: 25107984
Curr Opin Clin Nutr Metab Care. 2007 May;10(3):278-83
pubmed: 17414495
Regul Pept. 2011 Dec 10;172(1-3):69-76
pubmed: 21893106
Methods Enzymol. 2010;485:103-21
pubmed: 21050913
Mol Pharmacol. 2006 Sep;70(3):936-46
pubmed: 16798937
J Nucl Med. 2011 Jul;52(7):1110-8
pubmed: 21680701
J Clin Endocrinol Metab. 2002 Jun;87(6):2988
pubmed: 12050285
Nucl Med Biol. 2014 Jan;41(1):51-7
pubmed: 24183611
Hell J Nucl Med. 2011 Jan-Apr;14(1):8-14
pubmed: 21512658
Chem Rev. 2013 Feb 13;113(2):858-83
pubmed: 23198879
Drug Discov Today. 2007 Apr;12(7-8):276-88
pubmed: 17395087
Mol Imaging. 2018 Jan-Dec;17:1536012118809587
pubmed: 30394854
Bioorg Med Chem. 2013 Sep 1;21(17):5470-9
pubmed: 23816043
Peptides. 2011 Nov;32(11):2248-55
pubmed: 21619904
Nucl Med Biol. 2013 Apr;40(3):345-50
pubmed: 23394821
Eur J Endocrinol. 2004 Feb;150(2):173-84
pubmed: 14763915
J Biochem. 2012 Feb;151(2):119-28
pubmed: 22041973
Bioconjug Chem. 2008 Mar;19(3):719-30
pubmed: 18254581
Bioconjug Chem. 2000 Jul-Aug;11(4):527-32
pubmed: 10898574
Dalton Trans. 2011 Jun 21;40(23):6144-67
pubmed: 21350775
J Endocrinol. 2002 Mar;172(3):R7-11
pubmed: 11874717
J Med Chem. 2015 Jul 23;58(14):5395-407
pubmed: 26090686
Endocrine. 2019 May;64(2):393-405
pubmed: 30390209
Eur J Med Chem. 2018 Sep 5;157:1500-1511
pubmed: 30282322
Nucl Med Commun. 2018 Feb;39(2):140-146
pubmed: 29315139
Appl Radiat Isot. 2012 Apr;70(4):602-8
pubmed: 22326369
Pol J Vet Sci. 2012;15(1):189-97
pubmed: 22708377
Gastroenterology. 2007 May;132(6):2116-30
pubmed: 17498507
Medchemcomm. 2018 Sep 17;9(10):1761-1767
pubmed: 30429981
J Med Chem. 2009 Apr 23;52(8):2196-203
pubmed: 19323558
Curr Neuropharmacol. 2009 Mar;7(1):37-49
pubmed: 19721816
Mol Pharm. 2014 Nov 3;11(11):3930-7
pubmed: 24992368
Expert Opin Drug Deliv. 2009 Jan;6(1):1-16
pubmed: 19236204
Diabetes. 2001 Aug;50(8):1714-9
pubmed: 11473029
Bioconjug Chem. 2009 Feb;20(2):347-59
pubmed: 19173600
Clin Cancer Res. 2005 Dec 1;11(23):8295-303
pubmed: 16322288
Bioconjug Chem. 2012 Apr 18;23(4):771-84
pubmed: 22372770
Oncotarget. 2020 Sep 01;11(35):3286-3302
pubmed: 32934774
Trends Pharmacol Sci. 2004 Mar;25(3):113-7
pubmed: 15058279
Endocr J. 2011;58(8):707-10
pubmed: 21646729
Oncotarget. 2017 May 9;8(19):31368-31385
pubmed: 28404896
Int J Mol Imaging. 2012;2012:379807
pubmed: 23091717
J Clin Invest. 2006 Mar;116(3):637-41
pubmed: 16511600
Mol Cell Endocrinol. 2011 Jun 20;340(1):106-10
pubmed: 21356273
Oncotarget. 2017 Dec 21;9(7):7487-7500
pubmed: 29484126
Endocr Dev. 2013;25:122-34
pubmed: 23652398
Curr Opin Clin Nutr Metab Care. 2020 Sep;23(5):328-335
pubmed: 32618724
Peptides. 2013 May;43:13-9
pubmed: 23454172
Adv Drug Deliv Rev. 2008 Jan 3;60(1):29-49
pubmed: 17884239
J Med Chem. 2012 Sep 13;55(17):7437-49
pubmed: 22920150
Neuropharmacology. 2020 May 15;168:108011
pubmed: 32067989
Endocr Relat Cancer. 2016 Sep;23(9):R393-409
pubmed: 27552970
Mol Biol Cell. 2019 Oct 10;:mbcE19060326
pubmed: 31599699
Pharmacol Rev. 2005 Dec;57(4):541-6
pubmed: 16382107
Int J Mol Sci. 2017 Apr 05;18(4):
pubmed: 28379199
Endocr Dev. 2013;25:91-100
pubmed: 23652395
Nature. 2001 Jan 11;409(6817):194-8
pubmed: 11196643
Radiother Oncol. 2016 Dec;121(3):447-452
pubmed: 27544820
J Med Chem. 2015 May 28;58(10):4180-93
pubmed: 25905598